Against Pandemic Backdrop, Sepsis Test Developers Accelerated Commercial Plans in 2021

Numerous technologies in development to help with the diagnosis of sepsis have a singular objective ─ detect the condition as quickly as possible.

Related Keywords

Australia ,California ,United States ,Arizona ,Southborough ,Massachusetts ,Richmond Hill ,Victoria ,Acton ,Australian ,Jack Phillips ,Los Angeles ,Biosystemsceo John Sperzel ,University Of California ,Drug Administration ,Ibm ,Development Authority ,Nasdaq ,Human Service Biomedical Advanced Research ,Presymptom Health ,Resistance Panel ,Us Department Of Health ,Us Department Of Defense ,Drug Administration For The Prenosis Sepsis Immunoscore ,Alliance For Research ,Germany Based Molzym ,San Francisco Based Cytovale ,United Kingdom Based ,Arizona Based Accelerate Diagnostics ,Accelerate Diagnostics President ,France Based Biom ,Specific Diagnostic ,Specific Reveal Rapid ,Massachusetts Based Nanodx ,Chicago Based Prenosis ,Switzerland Based Roche Diagnostics ,Prenosis Sepsis Immunoscore ,Roche Elecsys ,Bluejay Diagnostics ,Ontario Based Qvella ,Advanced Animal Diagnostics ,Seattle Based Immunexpress ,Septicyte Rapid ,